Disease-specific Resource Utilization

Disease-Specific Resource Utilization is a metric that quantifies the consumption of healthcare resources uniquely attributable to the diagnosis, treatment, and management of a particular disease, distinguishing it from general or nonspecific healthcare utilization patterns.

88

Publications

7K

Citations

499

Authors

311

Institutions

Publications per year

2017–2026

24

Authors

499

  1. TB
    Tim Bancroft

    Optum (United States), United States

    3 publications · 103 citations

    3

    h-index

  2. PL
    Peter Lindgren

    Karolinska Institutet, Sweden

    2 publications · 117 citations

    2

    h-index

  3. JS
    Jan Stålhammar

    Uppsala University, Sweden

    2 publications · 63 citations

    2

    h-index

  4. AR
    Anna Ringborg

    Karolinska Institutet, Sweden

    2 publications · 117 citations

    2

    h-index

  5. AW
    Ancilla W. Fernandes

    AstraZeneca (United States), United States

    2 publications · 60 citations

    2

    h-index

1–5 of 499

Venues

  1. PubMed

    Repository · 6 publications · 171 citations

    6

    h-index

  2. Journal of Medical Economics

    JME · 6 publications · 227 citations

    6

    h-index

  3. Medical Care

    3 publications · 163 citations

    3

    h-index

  4. International Journal of Clinical Practice

    IJCP · 2 publications · 117 citations

    2

    h-index

  5. BMC Health Services Research

    2 publications · 104 citations

    2

    h-index

1–5